23 May 2013
Keywords: abbott, files, snda, kaletra, tablets, submitted, supplemental
Article | 09 May 2005
Abbott has submitted a supplemental New Drug Application to the US Food and Drug Administration seeking clearance to market a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 May 2005
16 May 2005
© 2013 thepharmaletter.com